Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanara MedTech Inc.

28.75
-0.0600-0.21%
Volume:17.79K
Turnover:514.61K
Market Cap:255.53M
PE:-21.44
High:29.50
Open:29.50
Low:28.56
Close:28.81
Loading ...

Sanara Medtech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

THOMSON REUTERS
·
25 Mar

Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

GlobeNewswire
·
25 Mar

Sanara Medtech Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
21 Mar

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

GlobeNewswire
·
12 Mar

Investors in Sanara MedTech (NASDAQ:SMTI) have seen strong returns of 215% over the past five years

Simply Wall St.
·
03 Mar

Biomimetic Innovations Ltd, an Affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment With Sanara Medtech Inc.

THOMSON REUTERS
·
24 Jan

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

GlobeNewswire
·
24 Jan

Sanara MedTech Price Target Maintained With a $44.00/Share by Cantor Fitzgerald

Dow Jones
·
23 Jan

Sanara MedTech Reports Q4 Preliminary Revenue Rose; Elizabeth Taylor Named CFO

MT Newswires Live
·
22 Jan

Sanara MedTech Announces Q4 And Full-Year 2024 Revenue Growth, Driven By Soft Tissue Repair Products; Revenue Expected Between $25.7M-$26.2M For Q4, FY24 Revenue Between $86M-$86.5M

Benzinga
·
22 Jan

Sanara MedTech appoints Elizabeth Taylor as CFO

TIPRANKS
·
22 Jan

Sanara MedTech enters exclusive license agreement with, investment in Biomimetic

TIPRANKS
·
22 Jan

Sanara Medtech: Expects Sales of Biasurge Will Normalize in Q1 2025

THOMSON REUTERS
·
22 Jan

Sanara Medtech Inc - Q4 Net Revenue Expected to Be $25.7 Mln-$26.2 Mln

THOMSON REUTERS
·
22 Jan

Sanara Medtech Inc - to Contribute up to €8 Million for 12.5% Equity in Bmi

THOMSON REUTERS
·
22 Jan

Sanara Medtech Inc. Announces Exclusive License and Distribution Agreement With, and Minority Investment in, Biomimetic Innovations Ltd

THOMSON REUTERS
·
22 Jan

Sanara Medtech Inc - License Agreement for Initial Five-Year Period With Renewal Option

THOMSON REUTERS
·
22 Jan

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

GlobeNewswire
·
22 Jan

Sanara Medtech Inc. Expands Executive Leadership Team With New Appointments

THOMSON REUTERS
·
22 Jan

Sanara Medtech Inc: Elizabeth Taylor Appointed Chief Financial Officer

THOMSON REUTERS
·
22 Jan